Menu
Search
|

Menu

Close
X

AngioDynamics Inc ANGO.OQ (NASDAQ Stock Exchange Global Select Market)

16.73 USD
-0.12 (-0.68%)
As of Feb 22
chart
Previous Close 16.84
Open 16.93
Volume 42,008
3m Avg Volume 70,669
Today’s High 17.20
Today’s Low 16.67
52 Week High 18.83
52 Week Low 14.81
Shares Outstanding (mil) 36.72
Market Capitalization (mil) 625.27
Forward P/E 178.12
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
3.00 Mean rating from 5 analysts

KEY STATS

Revenue (mm, USD)
FY18
172
FY17
350
FY16
354
FY15
357
EPS (USD)
FY18
0.006
FY17
0.132
FY16
-1.198
FY15
-0.095
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
178.12
32.90
Price to Sales (TTM)
vs sector
1.80
5.77
Price to Book (MRQ)
vs sector
1.22
5.41
Price to Cash Flow (TTM)
vs sector
22.23
23.42
Total Debt to Equity (MRQ)
vs sector
18.37
16.52
LT Debt to Equity (MRQ)
vs sector
17.41
12.22
Return on Investment (TTM)
vs sector
0.57
14.43
Return on Equity (TTM)
vs sector
0.71
16.13

EXECUTIVE LEADERSHIP

Howard Donnelly
Independent Chairman of the Board, Since 2014
Salary: --
Bonus: --
James Clemmer
President, Chief Executive Officer, Director, Since 2016
Salary: $625,000.00
Bonus: --
Michael Greiner
Chief Financial Officer, Executive Vice President, IR Contact Officer, Since 2017
Salary: $280,346.00
Bonus: $100,000.00
Robert Simpson
Senior Vice President and General Manager, Peripheral Vascular, Since 2017
Salary: $100,269.00
Bonus: --
Heather Daniels-Cariveau
Senior Vice President of Human Resources, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

14 Plaza Dr
LATHAM   NY   12110-2166

Phone: +1518.7981215

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

SPONSORED STORIES